MDxHealth affirms FY2026 sales guidance at $110.0M–$115.0M
MDxHealth (NASDAQ: MDXH) affirms FY2026 sales guidance of $110.000M–$115.000M versus a $98.814M estimate.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
MDxHealth (NASDAQ: MDXH) affirms FY2026 sales guidance of $110.000M–$115.000M versus a $98.814M estimate.